Management of Mandibular ORN: PENTO as Medical Treatment
NCT02368457
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
24
Enrollment
OTHER
Sponsor class
Conditions
Osteoradionecrosis
Interventions
DRUG:
Pentoxifylline and Tocopherol
Sponsor
Hospital Vall d'Hebron